Regulation (EU) 2017/745, the EU Medical Device Regulation. Vigilens automates essential requirements evidence for AI-powered medical devices, linking clinical evaluation, risk management, and post-market surveillance into a continuous governance record.
The EU MDR establishes a regulatory framework for medical devices placed on the EU market. Software, including AI-powered software, qualifies as a medical device when it is intended by the manufacturer for diagnosis, prevention, monitoring, prediction, prognosis, treatment, or alleviation of disease. AI medical devices must meet the general safety and performance requirements in Annex I.
Vigilens maps EU MDR essential requirements to executable controls in the AI development pipeline. For medical AI, this means tracking not just the software lifecycle, but the clinical evidence, risk management outputs, and post-market surveillance data that regulators and Notified Bodies expect.
AI-powered medical devices that qualify as high-risk under both the EU MDR and the EU AI Act face dual regulatory requirements. The EU AI Act's Digital Omnibus clarifies that existing sectoral legislation (including MDR) takes precedence where it overlaps, but AI-specific obligations in Articles 9-15 still apply. Vigilens maps both frameworks in a single governance record.
Essential requirements in your pipeline. Continuous evidence for Notified Body submissions.